Showing results (411-420 of 501) with videos related to
Sort By:
Pageof 51
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2021
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate CancerJamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.Theranostics|June 28, 2019
A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate CancerYu Jen Jan, Junhee Yoon, Jie-Fu Chen, et al.European Urology|May 12, 2023
Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate CancerPhilip Sutera, Yang Song, Kim Van der Eecken, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2020
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized TrialsWilliam C Jackson, Holly E Hartman, Robert T Dess, et al.JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.JAMA Network Open|November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality TherapyAnthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.Cancer Research|October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate CancerMartin Sjöström, Shuang G Zhao, Samuel Levy, et al.Cell|July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerDavid A Quigley, Ha X Dang, Shuang G Zhao, et al.Nature Medicine|March 31, 2015
Targeting the MLL complex in castration-resistant prostate cancerRohit Malik, Amjad P Khan, Irfan A Asangani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.Pageof 51